BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11106324)

  • 21. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
    Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C
    Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
    Quaglino P; Osella-Abate S; Savoia P; Bernengo MG; Cappello N; Cavallo F
    J Clin Oncol; 2007 Mar; 25(9):1140-1; author reply 1141-2. PubMed ID: 17369579
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
    Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T
    Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction.
    Keilholz U; Goldin-Lang P; Bechrakis NE; Max N; Letsch A; Schmittel A; Scheibenbogen C; Heufelder K; Eggermont A; Thiel E
    Clin Cancer Res; 2004 Mar; 10(5):1605-12. PubMed ID: 15014010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study).
    Fusi A; Collette S; Busse A; Suciu S; Rietz A; Santinami M; Kruit WH; Testori A; Punt CJ; Dalgleish AG; Spatz A; Eggermont AM; Keilholz U
    Eur J Cancer; 2009 Dec; 45(18):3189-97. PubMed ID: 19793643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of circulating malignant cells in patients with uveal melanoma].
    Fernandes BF; Antecka E; dos Passos G; Burnier MN
    Arq Bras Oftalmol; 2007; 70(4):593-8. PubMed ID: 17906753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.
    Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
    Mod Pathol; 2008 Mar; 21(3):326-33. PubMed ID: 18204435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of PCR-positive mRNA markers in peripheral blood and regional nodes of malignant melanoma patients. Melanoma Cooperative Group.
    Palmieri G; Pirastu M; Strazzullo M; Ascierto PA; Satriano SM; Motti ML; Botti G; Mozzillo N; Castello G; Cossu A; Lissia A; Tanda F
    Recent Results Cancer Res; 2001; 158():200-3. PubMed ID: 11092047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of tyrosinase mRNA from the blood of melanoma patients.
    Stevens GL; Scheer WD; Levine EA
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines.
    Johansson M; Takasaki A; Lenner L; Arstrand K; Kågedal B
    Melanoma Res; 2002 Jun; 12(3):193-200. PubMed ID: 12140375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of tyrosinase and tyrosinase-related protein 1 sequences from peripheral blood of melanoma patients using reverse transcription-polymerase chain reaction.
    Jin HY; Yamashita T; Minamitsuji Y; Omori F; Jimbow K
    J Dermatol Sci; 2003 Dec; 33(3):169-76. PubMed ID: 14643522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay.
    Kulik J; Nowecki ZI; Rutkowski P; Ruka W; Rochowska M; Skurzak H; Siedlecki JA
    Melanoma Res; 2001 Feb; 11(1):65-73. PubMed ID: 11254117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
    Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
    Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of the RT-PCR technique to detect melanoma cells in peripheral blood.
    Suárez A; Fra J; Alonso R; Sánchez R; Lacave AJ; Gutiérrez C
    Anticancer Res; 2002; 22(2B):1091-5. PubMed ID: 12168906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor markers in peripheral blood of patients with malignant melanoma: multimarker RT-PCR versus a luminoimmunometric assay for S-100.
    Berking C; Schlüpen EM; Schrader A; Atzpodien J; Volkenandt M
    Arch Dermatol Res; 1999 Sep; 291(9):479-84. PubMed ID: 10541877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
    Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
    J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases.
    Curry BJ; Myers K; Hersey P
    J Clin Oncol; 1999 Aug; 17(8):2562-71. PubMed ID: 10561323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
    Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
    Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma.
    Rappl G; Hasselmann DO; Rössler M; Ugurel S; Tilgen W; Reinhold U
    Ann N Y Acad Sci; 2001 Sep; 945():189-91. PubMed ID: 11708477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.